Avantor, Inc. Provides Revenue Guidance for the Fourth Quarter of 2020
January 11, 2021 at 06:04 am EST
Share
Avantor, Inc. provided revenue guidance for the fourth quarter of 2020. The company announced that fourth quarter 2020 unaudited revenue is expected to be approximately $1.79 billion resulting in estimated organic revenue growth of approximately 15%.
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
AVANTOR, INC. 
